All-Cause Mortality
15
4
4
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
88.9%
+2.4% vs benchmark
7%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
100-Year Human Aging Study
The Global Cardiovascular Risk Consortium
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events
Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)
ADL and CONUT for Predicting 1-year Mortality Risk in Older Adults After Hip Fracture
Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)
Hyperthyroid Follow-Up Study
Relationship Between Dietary Protein Intake and Fatal and Non-fatal Health Outcomes
Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
Korea Atherosclerosis Study-3
Effects of Insecticide Treated Bednets on Child Morbidity and Mortality